Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1921 - 1928 of 11616 results
Protecting Health Information Post Roe Part 1: Steps for Women
July 5, 2022| Blog| Viewpoint
Five Tips For Every In-House Counsel Launching an Open Source Software Program
July 5, 2022| Blog| Viewpoint
Read our Insights on ESG Regulatory Issues
July 1, 2022| Blog| Viewpoint
Global Cooperation Critical For Crypto Regulation
July 1, 2022| News
PBMs Continue to Draw Federal Scrutiny: PBM Transparency Act of 2022
June 30, 2022| Blog| Viewpoint
Justices To Mull Limits Of Fraud In NY Cases
June 30, 2022| News
U.S. Supreme Court to take up case of ex-Cuomo aide Joseph Percoco
June 30, 2022| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.